Enzo Biochem Inc ENZ:NYSE

RT Quote | NYSE | USD
Last | 4:10 PM EDT
2.38quote price arrow up+0.03 (+1.28%)
Volume
49,990
52 week range
2.23 - 4.15
Loading...
  • Open2.38
  • Day High2.45
  • Day Low2.37
  • Prev Close2.35
  • 52 Week High4.15
  • 52 Week High Date10/11/21
  • 52 Week Low2.23
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap115.93M
  • Shares Out48.71M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-25.86

KEY STATS

  • Open2.38
  • Day High2.45
  • Day Low2.37
  • Prev Close2.35
  • 52 Week High4.15
  • 52 Week High Date10/11/21
  • 52 Week Low2.23
  • 52 Week Low Date05/12/22
  • Market Cap115.93M
  • Shares Out48.71M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-25.86

RATIOS/PROFITABILITY

  • EPS (TTM)0.01
  • P/E (TTM)425.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)3.417M
  • ROE (TTM)0.47%
  • Revenue (TTM)118.18M
  • Gross Margin (TTM)45.11%
  • Net Margin (TTM)0.25%
  • Debt To Equity (MRQ)7.04%

EVENTS

  • Earnings Date06/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Enzo Biochem Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Enzo Biochem, Inc. (Enzo) is an integrated diagnostics, clinical lab, and life sciences company that is focused on delivering and applying advanced technology to produce reliable products and services for clinical needs. The Company develops, manufactures and sells technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's segments include Enzo Clinical Lab, Enzo Life Sciences and Enzo Therapeutics. Enzo...
Hamid Erfanian
Chief Executive Officer, Director
Kara Cannon
Chief Operating Officer
David Bench
Chief Financial Officer, Senior Vice President, Treasurer, Corporate Secretary
Address
60 EXECUTIVE BLVD
Farmingdale, NY
11735
United States

Top Peers

SYMBOLLASTCHG%CHG
PBYI
Puma Biotechnology Inc
1.88+0.05+2.73%
CLVS
Clovis Oncology Inc
0.8292+0.0477+6.10%
AKBA
Akebia Therapeutics Inc
0.38-0.0692-15.4052%
HBIO
Harvard Bioscience Inc
3.68-0.10-2.65%
SELB
Selecta Biosciences Inc
0.7703+0.0407+5.58%
DTIL
Precision BioSciences Inc
1.77+0.18+11.32%